Haemonetics HAE Europe — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's europe — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's europe — net revenues?
- Haemonetics (HAE) reported europe — net revenues of $52.9M in Q1 2026.
- How has Haemonetics's europe — net revenues changed year-over-year?
- Haemonetics's europe — net revenues increased by 25.1% year-over-year, from $42.28M to $52.9M.
- What is the long-term trend for Haemonetics's europe — net revenues?
- Over 4 years (2022 to 2026), Haemonetics's europe — net revenues has grown at a 3.1% compound annual growth rate (CAGR), from $163.52M to $185.02M.
- What does europe — net revenues mean?
- Represents the total income generated from the sale of goods and services within the European market after accounting for returns, allowances, and discounts. This metric serves as a primary indicator of regional market demand and the effectiveness of the company's commercial strategy in Europe. It is a key measure for evaluating top-line growth trends and the geographic contribution to the company's overall financial performance.